Lynparza 100 mg/1
olaparib · TABLET, FILM COATED · AstraZeneca Pharmaceuticals LP
Lynparza is a tablet, film coated containing olaparib at 100 mg/1, taken oral. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- Lynparza
- Generic Name
- olaparib
- NDC Code (Product)
0310-0569- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA208558
- Drug Class
- Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
- Marketing Start
- 08/17/2017
Recall History
AstraZeneca Pharmaceuticals LP
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Frequently Asked Questions
What is Lynparza used for?
Lynparza contains olaparib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Lynparza a controlled substance?
Lynparza is not classified as a controlled substance by the DEA.
What is the generic name for Lynparza?
The generic name for Lynparza is olaparib. There are no other listed brand versions of olaparib.
What is the NDC code for Lynparza 100 mg/1?
The NDC (National Drug Code) for Lynparza 100 mg/1 is 0310-0569, listed by AstraZeneca Pharmaceuticals LP.
Other Lynparza Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)